乳腺癌生物标志物的发展:2011年至2020年的文献计量分析
1Department of Breast Surgery, Hainan General Hospital, Hainan Affiliated Hospital of Hainan Medical University, Haikou, China. yangyu02@hainmc.edu.cn.
European review for medical and pharmacological sciences
|October 2, 2023
概括
这项文献计量研究显示,过去十年来,乳腺癌生物标志物研究的趋势越来越强. 微RNA和循环瘤DNA正在成为关键研究领域.
科学领域:
- 在瘤学瘤学.
- 生物标志物研究 生物标志物研究
- 图书统计学 图书统计学
背景情况:
- 乳腺癌是全球流行的一种恶性瘤.
- 了解研究趋势对于推进诊断和治疗策略至关重要.
- 生物标志物发现在针对乳腺癌的个性化医疗中发挥着关键作用.
研究的目的:
- 对2011-2020年乳腺癌生物标志物研究的全球科学成果进行文献计量分析.
- 识别关键趋势,有影响力的出版物和新兴的研究前沿.
- 绘制过去十年乳腺癌生物标志物研究的地图.
主要方法:
- 在科学网络核心集合 (WoSCC) 中进行文献搜索.
- 使用VOSviewer进行图书统计分析,以可视化边界和热点.
- 分析出版物数量,引用量,H指数,领先机构和经常使用的关键词.
主要成果:
- 总共有13,680篇论文被检索出来,显示出越来越多的出版趋势.
- 美国在出版物,引用和H指数方面处于领先地位.
- "表达"",microRNA"和"细胞"等关键词是最常见的;COVID-19相关的研究成为最近的一个热门话题.
结论:
- 对乳腺癌生物标志物的研究表明,乳腺癌的上升轨迹显著.
- 微RNAs (miRNAs) 和循环瘤DNAs (ctDNAs) 在最近的乳腺癌抑制和减弱研究中占据了重要地位.
- 美国仍然是乳腺癌生物标志物研究的有影响力的贡献者.
相关概念视频
Tumor Progression
6.4K
Tumor progression is a phenomenon where the pre-formed tumor acquires successive mutations to become clinically more aggressive and malignant. In the 1950s, Foulds first described the stepwise progression of cancer cells through successive stages.
Colon cancer is one of the best-documented examples of tumor progression. Early mutation in the APC gene in colon cells causes a small growth on the colon wall called a polyp. With time, this polyp grows into a benign, pre-cancerous tumor. Further...
Colon cancer is one of the best-documented examples of tumor progression. Early mutation in the APC gene in colon cells causes a small growth on the colon wall called a polyp. With time, this polyp grows into a benign, pre-cancerous tumor. Further...
6.4K
Cancer Survival Analysis
380
Cancer survival analysis focuses on quantifying and interpreting the time from a key starting point, such as diagnosis or the initiation of treatment, to a specific endpoint, such as remission or death. This analysis provides critical insights into treatment effectiveness and factors that influence patient outcomes, helping to shape clinical decisions and guide prognostic evaluations. A cornerstone of oncology research, survival analysis tackles the challenges of skewed, non-normally...
380


